1,4,8,12-TETRAAZACYCLOPENTADECANE,MIN. 98%

Product Information

Molecular Formula:
C11H26N4
Molecular Weight:
214.35
Description
1,4,8,12-Tetraazacyclopentadecane is primarily utilized in biomedical research, specifically in the development of potential cancer treatment drugs. Its unique structure allows for versatile metal ion complexation, crucial in anticancer agents.
Synonyms
1,4,8,12-Tetraazacyclopentadecane; 1,4,8,12-tetrazacyclopentadecane; 1,4,8,12-Tetraazacyclopentadecane, 97%
IUPAC Name
1,4,8,12-tetrazacyclopentadecane
Canonical SMILES
C1CNCCCNCCNCCCNC1
InChI
InChI=1S/C11H26N4/c1-4-12-6-2-8-14-10-11-15-9-3-7-13-5-1/h12-15H,1-11H2
InChI Key
KUFDRRWNPNXBRF-UHFFFAOYSA-N
Melting Point
96-102 °C (lit.)
Flash Point
Not applicable
Purity
0.97

Safety Information

Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338

Computed Properties

XLogP3
-0.6
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
0
Exact Mass
214.21574685 g/mol
Monoisotopic Mass
214.21574685 g/mol
Topological Polar Surface Area
48.1Ų
Heavy Atom Count
15
Formal Charge
0
Complexity
116
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
JP-2021080483-A Complex 2021-03-04
WO-2022042977-A1 Detergent composition 2020-08-28
WO-2022042989-A1 Surfactant and detergent composition 2020-08-28
WO-2022043042-A1 Detergent composition 2020-08-28
WO-2022043045-A1 Detergent composition 2020-08-28
WO-2022043138-A1 Surfactant and detergent composition 2020-08-28
JP-2022032446-A Fiber treatment agent composition 2020-08-12
WO-2022024054-A1 Odorants and compositions comprising odorants 2020-07-31
EP-3940806-A1 Method of modifying the structure of perovskite films 2020-07-14
EP-3936593-A1 Cleaning compositions and uses thereof 2020-07-08

Literatures

PMID Publication Date Title Journal
20128813 2010-05-01 Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease British journal of pharmacology
19114114 2009-05-01 Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donor in renal hypertensive rats Nitric oxide : biology and chemistry
21200551 2007-12-18 [(1-Azulen-yl)methane-thiol-ato-κS](1,4,8,12-tetra-azacyclo-penta-decane-κN)zinc(II) perchlorate Acta crystallographica. Section E, Structure reports online
16759899 2006-12-01 Structural and spectroscopic properties of trans-difluoro(1,4,8,12-tetraazacyclopentadecane)chromium(III) perchlorate hydrate Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
16054406 2005-11-01 The complex trans-[RuCl([15]aneN4NO]2+ induces rat aorta relaxation by ultraviolet light irradiation Nitric oxide : biology and chemistry
15135361 2004-03-01 A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation Nitric oxide : biology and chemistry
9875379 1998-01-01 Design, synthesis and structure relationships of new N,N',N',N''-tetrakis (omega-amino alkyl) tetraazamacrocycles Antiviral chemistry & chemotherapy
7276 1976-01-01 [Drug-drug interactions (author's transl)] Arzneimittel-Forschung
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket